ENTITY
Atea Pharmaceuticals

Atea Pharmaceuticals (AVIR US)

3
Analysis
Health Care • United States
Atea Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on discovery of oral direct-acting antiviral therapies. Atea Pharmaceuticals serves patients, healthcare professionals, pharmaceutical, and biotechnology industries worldwide.
more
Exchange Announcement • 13 Aug 2026 04:15

Current Report (Form 8-K | Period ending 2026-08-12)

Exchange Announcement • 12 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 23 Jun 2026 04:53

Current Report (Form 8-K | Period ending 2026-06-18)

Exchange Announcement • 13 May 2026 04:17

Current Report (Form 8-K | Period ending 2026-05-12)

Exchange Announcement • 12 May 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

x